Lorazepam
Sold as Ativan, Ativan sl, Tranqipam
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
Drag to rotate. Structure from PubChem CID 3958.
Background
Registration
- Applicants
- 2
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Akromed Products (Pty) Ltd | Ativan, Ativan sl | 0,5 mg, 1 mg, 2 mg, 2,5 mg | D0126, D0128, R0320, X0082 | S5 | None |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Ativan, Ativan sl, Tranqipam | 0,5 mg/1 mg/2,5 mg, 1 ml, 1 mg | J0295, R0319, U0038, U0039 | S5 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ativan 1 mg* EACH TABLET CONTAINS LORAZEPAM 1 mg | 1 mg | D0126D/2.6/126 | Registered | S5 | None |
| Ativan 2,5 mg* EACH TABLET CONTAINS LORAZEPAM 2,5 mg | 2,5 mg | D0128D/2.6/128 | Registered | S5 | None |
| Ativan injection EACH 1 ml CONTAINS LORAZEPAM 4 mg | 1 mlInjection | J0295JX/2.6/295Approved 23 March 2015 | Registered | S5 | PIPIL |
| Ativan sl 1 MG EACH TABLET CONTAINS LORAZEPAM 1 mg | 1 mg | R0319R/2.6/319 | Registered | S5 | None |
| Ativan sl 2 mg* EACH TABLET CONTAINS LORAZEPAM 2 mg | 2 mg | R0320R/2.6/320 | Registered | S5 | None |
| Tranqipam - 1 EACH TABLET CONTAINS LORAZEPAM 1 mg | 0,5 mg/1 mg/2,5 mgTablet | U0038U/2.6/38Approved 5 February 1990 | Registered | S5 | PI |
| Tranqipam - 2,5 EACH TABLET CONTAINS LORAZEPAM 2,5 mg | 0,5 mg/1 mg/2,5 mgTablet | U0039U/2.6/39Approved 5 February 1990 | Registered | S5 | PI |
| Ativan 0,5 mg* EACH TABLET CONTAINS LORAZEPAM 0,5 mg | 0,5 mg | X0082X/2.6/82 | Registered | S5 | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Lorazepam
S5: Lorazepam
Consolidated Schedules 06 July 2026, line 9515
Pharmacological class: Tranquillisers. (class 2.6)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Ativan injection, Pharmacare limited û woodmead is scheduled S5 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.